Recession USA 2020
Business

Addex, Janssen Pharma on go with Phase 2a study of JNJ-40411813 (ADX71149) in epilepsy

Addex, Janssen Pharma on go with Phase 2a study of JNJ-40411813 (ADX71149) in epilepsy

Related posts

R.I.P. Black Friday? Pandemic, online shopping lead to thin crowds

jkslogan19@gmail.com

Cerence makes strategic investment in automotive data company CerebrumX

Matinas Bio to evaluate oral formulations of Gilead’s antiviral remdesivir, shares up 15%

jkslogan19@gmail.com

Leave a Comment